📰 Polypid Daily News
Polypid Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Polypid Daily. Real-time updates on events, politics, business and more.
June 1, 2024
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report)’s stock price rose 0.2% during mid-day trading on Thursday . The company traded as high as $4.67 and last traded at $4.50. Approximately 5,148 shares traded hands during trading, a decline of 9% from the average daily volume of 5,662 shares. The stock had previously closed at $4.49. […]
June 1, 2024
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) rose 0.2% on Thursday . The stock traded as high as $4.67 and last traded at $4.50. Approximately 5,148 shares changed hands during mid-day trading, a decline of 9% from the average daily volume of 5,662 shares. The stock had previously closed at $4.49. Wall Street Analyst Weigh […]
May 31, 2024
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) shares traded up 0.2% during trading on Thursday . The stock traded as high as $4.67 and last traded at $4.50. 5,148 shares were traded during mid-day trading, a decline of 9% from the average session volume of 5,662 shares. The stock had previously closed at $4.49. Analyst […]
May 5, 2024
HC Wainwright reaffirmed their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, Q3 2025 earnings […]
May 5, 2024
HC Wainwright reiterated their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, […]
April 11, 2024
PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Earnings and Valuation This table compares PolyPid and […]
April 9, 2024
PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of recent […]
January 11, 2024
PolyPid (NASDAQ:PYPD – Get Free Report) and Assure (NASDAQ:IONM – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings. Risk and Volatility PolyPid has a beta of 1.45, […]
November 30, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the recipient of a significant decline in short interest in November. As of November 15th, there was short interest totalling 1,000 shares, a decline of 68.8% from the October 31st total of 3,200 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average […]
September 28, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 1,500 shares, a drop of 88.7% from the August 31st total of 13,300 shares. Based on an average trading volume of 5,500 shares, the short-interest ratio is […]